ozempic tirzepatide or semaglutide GLP-1 Vs Zepbound For Weight Loss TGA issues warning over GLP-1-based

Tendon and ligament repair shows similarly promising preclinical data

Given the increasing interest in peptide drugs because of their low production costs, high potency, selectivity, and biological stability, our research underscores the potential of finding a peptide analgesic that precisely targets and modulates TRPV1 without causing adverse effects

As demonstrated above, tirzepatide (the active ingredient in Zepbound) appears to lead to greater weight loss than semaglutide (Wegovy) by around 9%

It selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1

Yeast infections versus UTIs Some people confuse UTIs with yeast infections, and it is worth clarifying the difference